ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.820
+0.160 (4.37%)
Jan 12, 2026, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $473.21 million as of January 12, 2026. Its market cap has increased by 141.09% in one year.
Market Cap
473.21M
Enterprise Value
695.91M
1-Year Change
141.09%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $473.21M, a decrease of -76.83%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 473.21M | 8.22% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |